semaglutide 7.2 mg clinical trial Efficacy and safety of once-weekly 2·0 versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B SELECT Trial

This engine uses high octane for real performance

Researchers examine this compound as a tri-agonist that interacts with SP-1, GIP, and glucagon receptors at the molecular level

doi: 10.1038/nature22394 44 FinanBMaTOttawayNMllerTDHabeggerKMHeppnerKMet al

When you maintain a calorie deficit , your body begins drawing on stored energy from multiple fat stores

Response-Based Approach: Treatment duration is individualized based on objective measurements including body composition analysis (DEXA scan, bioimpedance), waist circumference, metabolic markers, and subjective response

4.6.2 Retinal disease Diabetic retinopathy (DR) is the most prevalent microvascular complication of diabetes and the leading cause of preventable blindness among working-age individuals (81)